NMC
CBIO

NEA Management Company’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,835,039
Closed -$11.5M 42
2024
Q1
$11.5M Sell
3,835,039
-929,401
-20% -$2.79M 0.71% 27
2023
Q4
$11.2M Hold
4,764,440
0.75% 27
2023
Q3
$7.15M Hold
4,764,440
0.55% 29
2023
Q2
$8.29M Hold
4,764,440
0.63% 29
2023
Q1
$6M Sell
4,764,440
-4,203,266
-47% -$5.3M 0.42% 33
2022
Q4
$27.2M Sell
8,967,706
-121,335
-1% -$368K 1.53% 17
2022
Q3
$5.01M Hold
9,089,041
0.25% 43
2022
Q2
$5.43M Hold
9,089,041
0.28% 42
2022
Q1
$10.4M Hold
9,089,041
0.3% 40
2021
Q4
$13.1M Hold
9,089,041
0.26% 41
2021
Q3
$19.9M Hold
9,089,041
0.24% 38
2021
Q2
$21.1M Hold
9,089,041
0.27% 41
2021
Q1
$27.4M Hold
9,089,041
0.61% 35
2020
Q4
$34.2M Hold
9,089,041
0.9% 27
2020
Q3
$27.9M Hold
9,089,041
1.18% 22
2020
Q2
$34.2M Hold
9,089,041
1.37% 19
2020
Q1
$20.7M Hold
9,089,041
1.08% 20
2019
Q4
$48.1M Hold
9,089,041
2.27% 15
2019
Q3
$39.2M Hold
9,089,041
3.24% 9
2019
Q2
$108M Hold
9,089,041
7.59% 2
2019
Q1
$113M Hold
9,089,041
5.88% 4
2018
Q4
$86.1M Hold
9,089,041
3.41% 7
2018
Q3
$131M Hold
9,089,041
5.65% 5
2018
Q2
$147M Buy
9,089,041
+504,913
+6% +$8.14M 6.87% 4
2018
Q1
$139M Hold
8,584,128
6.2% 4
2017
Q4
$144M Hold
8,584,128
5.97% 2
2017
Q3
$120M Hold
8,584,128
4.21% 4
2017
Q2
$95.8M Hold
8,584,128
3.49% 5
2017
Q1
$46.6M Hold
8,584,128
1.62% 11
2016
Q4
$52.4M Hold
8,584,128
2.08% 10
2016
Q3
$61.4M Hold
8,584,128
2.75% 9
2016
Q2
$62.4M Hold
8,584,128
3.24% 8
2016
Q1
$51.2M Buy
8,584,128
+10
+0% +$60 3.4% 9
2015
Q4
$49.1M Buy
8,584,118
+8,983
+0.1% +$51.4K 3.13% 9
2015
Q3
$48M Hold
8,575,135
3.16% 10
2015
Q2
$68.2M Hold
8,575,135
3.56% 8
2015
Q1
$71.3M Hold
8,575,135
3.23% 10
2014
Q4
$61.7M Hold
8,575,135
2.99% 10
2014
Q3
$59.5M Hold
8,575,135
3.02% 10
2014
Q2
$72.3M Hold
8,575,135
3.39% 10
2014
Q1
$140M Buy
+8,575,135
New +$140M 6.87% 6